The rising interest in GLP-1 agonists for diabetes has generated a discussion about application forms : skin-applied devices versus tablets . Typically, GLP-1 treatments were solely available in tablet https://elaineowad324205.bloggazza.com/39702176/glp-1-transdermal-delivery-systems-vs-pills-is-suitable-for-individuals